CAS: 1320346-97-1
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
GLPG0187 REF: AN-AG01DDTECAS: 1320346-97-1 | ≥97%(HPLC) | 182.00 €~610.00 € | Fri 17 May 24 | |
GLPG0187 REF: TM-T4259CAS: 1320346-97-1 | 99.12% | 46.00 €~1,170.00 € | Fri 24 May 24 | |
GLPG-0187 REF: 3D-VCC34697CAS: 1320346-97-1 | Min. 95% | To inquire | Fri 28 Jun 24 |
Ref: AN-AG01DDTE
25mg | 182.00 € | |
50mg | 194.00 € | |
100mg | 288.00 € | |
250mg | 488.00 € |
Estimated delivery in United States, on Friday 17 May 2024
GLPG0187
CAS:1320346-97-1
GLPG0187, a broad spectrum integrin receptor antagonist, inhibits αvβ1-integrin (IC50: 1.3 nM).
Formula:
C29H37N7O5S
Purity:
99.12%
Color and Shape:
Solid
Molecular weight:
595.71
Ref: TM-T4259
1mg | 46.00 € | |
5mg | 101.00 € | |
10mg | 149.00 € | |
25mg | 245.00 € | |
50mg | 362.00 € | |
100mg | 538.00 € | |
500mg | 1,170.00 € | |
1ml*10 (DMSO) | 133.00 € |
Estimated delivery in United States, on Friday 24 May 2024
GLPG-0187
CAS:1320346-97-1
GLPG-0187 is an anti-cancer drug that inhibits the proliferation of cancer cells by inducing apoptosis. …
Formula:
C29H37N7O5S
Purity:
Min. 95%
Molecular weight:
595.71 g/mol
Ref: 3D-VCC34697
1mg | To inquire | |
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire |
Estimated delivery in United States, on Friday 28 Jun 2024